There could be an upside to incorporating AI for the FDA. Using AI to assist in final drug reviews would "represent a chance ...

The Food and Drug Administration is rolling out an aggressive plan to make generative AI a linchpin in its decision-making, ...

Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...

The Food and Drug Administration just announced that it will immediately start using AI across all of its centers, after ...

FDA's plan to deploy an AI tool to assist with scientific review process raises questions about transparency and risks.

During the AAPS National Biotech Conference 2025, pharmaphorum’s Jonah Comstock sat down with Eric Luellen, the founder and CTIO of Turing Biosciences. Luellen shared the company's ambitious mission ...

The U.S. Food and Drug Administration said on Thursday all its centers will deploy artificial intelligence internally ...

The FDA has started exploring how AI can be used to accelerate drug approvals in collaboration with OpenAI amid oversight ...

The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...

The FDA  plans to launch generative AI across all of its centers by June 30. The agency has also appointed its first chief AI ...

OpenAI has reportedly met with officials from the Food and Drug Administration to discuss how AI could speed up drug ...

The FDA has appointed its first chief artificial intelligence officer, with an eye on supporting the agency’s internal IT ...